QUEBEC CITY, Nov. 27 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS) today announced it will webcast the presentations from its Analyst Day to be held in Toronto on Wednesday, November 29, 2006 starting at 9:00 a.m. ET. Company management and opinion leaders will present and discuss the development of its lead compounds cetrorelix, ozarelix and perifosine, as well as other promising product candidates. A live audio webcast of this presentation will be available on AEterna Zentaris' website at http://www.aeternazentaris.com/ in the Investors section. A replay will also be available for a period of 30 days. About AEterna Zentaris Inc. AEterna Zentaris Inc. is a growing global biopharmaceutical company focused on endocrine therapy and oncology, with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at http://www.aeternazentaris.com/. DATASOURCE: AETERNA ZENTARIS INC. CONTACT: Media Relations: Paul Burroughs, (418) 652-8525 ext. 406, ; Investor Relations: Jenene Thomas, (418) 655-6420, (908) 996-3154,

Copyright